RRAD
(Ras-Related Associated with Diabetes (RRAD))
Protein Region
Middle Region
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-RRAD antibody (Catalog #: ARP56567_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
RRAD
Reactivité: Humain, Souris
Hôte: Synthetic
BP, BI
Indications d'application
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
RRAD
(Ras-Related Associated with Diabetes (RRAD))
Synonymes
ZGC:63471 Peptide, RRAD Peptide, RAD Peptide, RAD1 Peptide, REM3 Peptide, Rad Peptide, RRAD, Ras related glycolysis inhibitor and calcium channel regulator Peptide, Ras-related associated with diabetes Peptide, RRAD Peptide, Rrad Peptide
Sujet
RRAD may play an important role in cardiac antiarrhythmia via the strong suppression of voltage-gated L-type Ca2+ currents. RRAD regulates voltage-dependent L-type calcium channel subunit alpha-1C trafficking to the cell membrane. RRAD inhibits cardiac hy
Alias Symbols: RAD, RAD1, REM3
Protein Interaction Partner: CALM1,CAMK2G,CSNK2A1,NME1,PRKACA,PRKCA,PRKCB,TPM2,YWHAZ,CAMK2G,NME1,TPM2,Tpm2,YWHAZ